Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 251 | 33,492 |
| Gross Profit | 251 | 33,492 |
| Operating Expenses | 67,533 | 64,163 |
| Operating Income | -67,282 | -30,671 |
| Other Income | 1,909 | 2,023 |
| Pre-tax Income | -65,373 | -28,648 |
| Income Tax | N/A | 72 |
| Net Income Continuous | -65,373 | -28,720 |
| Net Income | $-65,373 | $-28,720 |
| EPS Basic Total Ops | -5.81 | -35.78 |
| EPS Basic Continuous Ops | -5.81 | -35.78 |
| EPS Diluted Total Ops | -5.81 | -35.78 |
| EPS Diluted Continuous Ops | -5.81 | -35.78 |
| EPS Diluted Before Non-Recurring Items | -5.49 | N/A |
| EBITDA(a) | $-64,851 | $-28,405 |